Campylobacter species and Guillain-Barre syndrome

Clinical Microbiology Reviews

Volumn 11, Issue 3, 1998, Pages 555-567

  Nachamkin, Irving ^a   Allos, Ban Mishu ^b   Ho, Tony ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

AUTOIMMUNE DISEASE; CAMPYLOBACTER; DEMYELINATING DISEASE; GUILLAIN BARRE SYNDROME; MOLECULAR MIMICRY; PARALYSIS; PERIPHERAL NEUROPATHY; REVIEW;

EID: 0031852829     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/cmr.11.3.555     Document Type: Review

References (186)

1. Adams, D., J. D. Gibson, P. K. Thomas, J. R. Batchelor, R. A. Hughes, L. Kennedy, H. Festenstein, and J. Sachs. 1977. HLA antigens in Guillain-Barre syndrome. Lancet ii:504-505.
2. Adams, R. D., and M. Victor. 1993. Diseases of the peripheral nerves, p. 1117-1169. In R. D. Adams and M. Victor (ed.). Principles of neurology. McGraw-Hill, Inc., New York, N.Y.
3. Albert, M. J., A. Leach, V. Asche, J. Hennessy, and J. L. Penner. 1992. Serotype distribution of Campylohacter jejuni and Campylobacter coil isolated from hospitalized patients with diarrhea in central Australia. J. Clin. Microbiol. 30:207-210.
4. Alm, R. A., P. Guerry, M. E. Power, H. Lior, and T. J. Trust. 1991. Analysis of the role of flagella in the heat-labile Lior serotyping scheme of thermophilic campylobacters by mutant allele exchange. J. Clin. Microbiol. 29: 2438-2445.
5. Apostolski, S., S. A. Sadiq, A. Hays, M. Corbo, L. Suturkova-Milosevic, P. Chaliff, K. Stefansson, R. G. LeBaron, E. Ruoslahti, A. P. Hays, and N. Latov. 1994. Identification of Gal(β1-3)GalNAc bearing glycoproteins at the nodes of Ranvier in peripheral nerve. J. Neurosci. Res. 38:134-141.
6. Arnason, B. G. W., and B. Soliven. 1993. Acute inflammatory demyelinating polyradiculopathy, p. 1437-1497. In P. J. Dyck, P. K. Thomas, J. W. Griffin, P. A. Low, and J. F. Poduslo (ed.), Peripheral neuropathy. W. B. Saunders, Philadelphia, Pa.
7. Arvidson, B. 1977. Cellular uptake of exogenous horseradish peroxidase in mouse peripheral nerve. Acta Neuropathol. 37:35-41.
8. Asbury, A. K., B. G. Arnason, and R. D. Adams. 1969. The inflammatory lesion in idiopathic polyneuritis. Medicine 48:173-215.
9. Aspinall, G. O., S. Fujimolo, A. G. McDonald, H. Pang, L. A. Kurjanczyk, and J. L. Penner. 1994. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure. Infect. Immun. 62:2122-2125.
10. Aspinall, G. O., A. G. McDonald, and H. Pang. 1994. Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of O antigen chains from the serostrain and two bacterial isolates from patients with Guillain-Barre syndrome. Biochemistry 33:250-255.
11. Aspinall, G. O., A. G. McDonald, H. Pang, L. A. Kurjanczyk, and J. L. Penner. 1994. Lipopolysaccharides of Campylobacter jejuni serotype 0:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barre syndrome. Biochemistry 33:241-249.
12. Aspinall, G. O., A. G. McDonald, T. S. Raju, H. Pang, L. A. Kurjanczyk, J. L. Penner, and A. P. Moran. 1993. Chemical structure of the core region of Campylobacter jejuni serotype O.2 lipopolysaccharide. Eur. J. Biochem. 213:1029-1037.
13. Aspinall, G. O., A. G. McDonald, T. S. Raju, H. Pang, A. P. Molan, and J. L. Penner. 1993. Chemical structures of the core regions of Campylobacter jejuni serotypes O:1, O:4, O:23, and O:36 lipopolysaccharides. Eur. J. Biochem. 213:1017-1027.
14. Bansil, S., F. A. Mithen, S. D. Cook, A. Sheffet, and C. Rohowsky-Kochan. 1991. Clinical correlation with serum-soluble interleukin-2 receptor levels in Guillain-Barre syndrome. Neurology 41:1302-1305.
15. Berciano, J., F. Coria, F. Monton, J. Calleja, J. Figols, and M. Lafarga. 1993. Axonal form of Guillain-Barre syndrome: evidence for macrophage-associated demyelination. Muscle Nerve 16:744-751.
16. Birchem, R., F. A. Mithen, K. M. L'Empereur, and M. M. Wessels. 1987. Ultrastructural effects of Guillain-Barre serum in cultures containing only rat Schwann cells and dorsal root ganglion neurons. Brain Res. 421:173-185.
17. Black, R. E., M. M. Levine, M. L. Clements, T. P. Hughs, and M. J. Blaser. 1988. Experimental Campylobacter jejuni infections in humans. J. Infect. Dis. 157:472-480.
18. Blaser, M. J., and D. J. Duncan. 1984. Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme-linked immunosorbent assay. Infect. Immun. 44:292-298.
19. Bolton, F. J., D. . Hutchinson, and D. Coates. 1984. Blood-free selective medium for isolation of Campylobacter jejuni from feces. J. Clin. Microbiol. 19:169-171.
20. Bolton, F. J., and L. Robertson. 1982. A selective medium for isolating Campylobacter jejuni/coli. J. Clin. Pathol. 35:462-467.
21. Breman, J. G., and J. S. Hayner. 1984. Guillain-Barre syndrome and its relationship to swine influenza vaccination in Michigan, 1976-1977. Am. J. Epidemiol. 119:880-889.
22. Briscoe, D. M., J. B. McMenamin, and N. V. O'Donahue. 1987. Prognosis in Guillain-Barre syndrome. Arch. Dis. Child. 62:733-735.
23. Buchwald, B., A. Weishaupt, K. V. Toyka, and J. Dudel. 1995. Immunoglobulin G from a patient with Miller-Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice. Neurosci. Lett. 201:163-166.
24. Calva, J. J., G. M. Ruiz-Palacios, A. B. Lopez-Vidal, A. Ramos, and R. Bojalil. 1988. Cohort study of intestinal infection with Campylobacter in Mexican children. Lancet i:503-505.
25. Campbell, A. M. G. 1958. The aetiology of polyneuritis. Proc. R. Soc. Med. 51:157-159.
26. Chiba, A., S. Kusinoki, S. Kuwata, T. Juji, Y. Sibata, and I. Kanazawa. 1995. HLA and anti-GQ1b IgG antibody in Miller Fisher syndrome and Guillain-Barre syndrome. J. Neuroimmunol. 61:85-88.
27. Chiba, A., S. Kusunoki, H. Obata, R. Machinami, and I. Kanazawa. 1993. Serum anti-GQ1b antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barre syndrome: clinical and immunohistochemical studies. Neurology 43:1911-1917.
28. Chiba, A., S. Kusunoki, T. Shimizu, and I. Kanazawa. 1992. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann. Neurol. 31:677-679.
29. Coe, C. J. 1989. Guillain-Barre syndrome in Korean children. Yonsei Med. J. 30:81-87.
30. Cole, G. F., and D. J. Matthew. 1987. Progress in severe Guillain-Barre syndrome. Arch. Dis. Child. 62:288-291.
31. Constant, O. C., C. C. Bentley, A. M. Denman, J. R. Lehane, and H. E. Larson. 1983. The Guillain-Barre syndrome following Campylobacter enteritis with recovery after plasmapheresis. J. Infect. 6:89-91.
32. Corbo, M., A. Quattrini, N. Latov, and A. P. Hays. 1993. Localization of GM1 and Gal(β1-3)GalNAc antigenic determinants in peripheral nerve. Neurology 43:809-814.
33. Cros, D., and W. J. Triggs. 1994. There are no neurophysiologic features characteristic of "axonal" Guillain-Barre syndrome. Muscle Nerve 17:675-677.
34. de Jager, A. E., and H. J. Sluiter. 1991. Clinical signs in severe Guillain-Barre syndrome: analysis of 63 patients. J. Neurol. Sci. 104:143-150.
35. Dowling, P. C. 1981. Role of infection in Guillain-Barre syndrome: laboratory confirmation of herpesviruses in 41 cases. Ann. Neurol. 9:44-55.
36. Dowling, P. C., J. P. Menonna, and S. D. Cook. 1977. Guillain-Barre syndrome in greater New York-New Jersey. JAMA 238:317-318.
37. Feasby, T. E., J. J. Gilbert, W. F. Brown, C. F. Bolton, A. F. Hahn, W. F. Koopman, and D. W. Zochodne. 1986. An acute axonal form of Guillain-Barre polyneuropathy. Brain 109:1115-1126.
38. Feasby, T. E., A. F. Hahn, W. F. Brown, C. F. Bolton, J. J. Gilbert, and W. J. Koopman. 1993. Severe axonal degeneration in acute Guillain-Barre syndrome: evidence of two different mechanisms? J. Neurol. Sci. 116:185-192.
39. Fisher, M. 1956. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia ataxia and areflexia). N. Engl. J. Med. 255:57-65.
40. French Cooperative Group on Plasma Exchange in Guillain-Barre Syndrome. 1987. Efficacy of plasma exchange in Guillain-Barre syndrome: role of replacement fluids. Ann. Neurol. 22:753-761.
41. Fry, B. N., V. Korolik, B. J. J. Teunis, J. A. ten Brinke, M. T. T. Pennings, and B. A. M. Van Der Zeijst. 1997. Identification of the locus encoding Campylobacter O-antigens and its expression in Escherichia coli, p. 78-85. In Molecular biology of Campylobacter: natural transformation and lipopoly-saccharides. Thesis. University of Utrecht, Utrecht, The Netherlands.
42. Fry, B. N., J. A. ten Brinke, B. J. J. Teunis, R. Zalm, V. Korolik, and B. A. M. Van Der Zeijst. 1997. Molecular characterization of the lipopolysaccharide biosynthesis locus of Campylobacter jejuni 81116, p. 88-116. In Molecular biology of Campylobacter: natural transformation and lipopolysaccharides. Thesis. University of Utrecht. Utrecht, The Netherlands.
43. Gao, C. Y., T. W. Ho, G. L. Wang, G. H. Zhang, J. X. Mao, C. Y. Li, J. W. Griffin, A. K. Asbury, G. M. McKhann, and D. R. Cornblath. 1997. Electrodiagnostic studies of Guillain-Barre syndrome in northern China, p. 119-128. In J. Kimura and R. Kaji (ed.). Physiology of ALS and related disorders. Elsevier, Amsterdam. The Netherlands.
44. Georges-Courbot, M. C., C. Baya, A. M. Beraud, D. M. Y. Meunier, and A. J. Georges. 1986. Distribution and serotypes of Campylobacter jejuni and Campylobacter coli in enteric Campylobacter strains isolated from children in the Central African Republic. J. Clin. Microbiol. 23:592-594.
45. Glaze, D. G. 1992. Guillain-Barre syndrome, p. 470-482. In R. D. Feigen and J. D. Cherry (ed.), Pediatric infectious diseases, 4th ed. W. B. Saunders, Philadelphia, Pa.
46. Goddard, E. A., A. J. Lastovica, and A. C. Argent. 1997. Campylobacter O:41 isolation in Guillain-Barre syndrome. Arch. Dis. Child. 76:526-528.
47. Goossens, H., L. Vlaes, I. Galand, C. Van den Borre, and J.-P. Butzler. 1989. Semisolid blood-free selectrve-motility medium tor the isolation of campylobacters from stool specimens. J. Clin. Microhiol. 27:1077-1080.
48. Gorodezky, C., B. Varela, L. E. Castro-Escobar, A. Chavez-Negrete, A. Escobar-Gutierrez, and J. Martinez-Mata. 1983. HLA-DR antigens in Mexican patients with Guillain-Barre sydrome. J. Neuroimmunol. 4:1-7.
49. Griffin, J. W., C. Y. Li, T. W. Ho, M. Tian, C. Y. Gao, P. Xue, B. Mishu, D. R. Cornblath, C. Macko, G. M. McKhann, and A. K. Asbury. 1996. Pathology of the motor-sensory axonal Guillain-Barre syndrome. Ann. Neurol. 39:17-28.
50. Griffin, J. W., C. Y. Li, T. W. Ho, P. Xue, C. Macko, D. R. Cornblath, C. Y. Gao, C. Yang, M. Tian, B. Mishu, G. M. McKhann, and A. K. Asbury. 1995. Guillain-Barre syndrome in northern China: the spectrum of neuropathologic changes in clinically defined cases. Brain 118:577-595.
51. Griffin, J. W., C. Y. Li, C. Macko, T. W. Ho, S.-T. Hsieh, P. Xue, F. A. Wang, D. R. Cornblath, G. M. McKhann, and A. K. Asbury. 1996. Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barre syndrome. J. Neurocytol. 25:33-51.
52. Gruenewald, R., A. H. Ropper, H. Lior, J. Chan, R. Lee, and V. S. Molinaro. 1991. Serologic evidence of Campylohacter jejuni/coli enteritis in patients with Guillain-Barre syndrome. Arch. Neurol. 48:1080-1082.
53. Guillain-Barre Study Group. 1985. Plasmapheresis and acute Guillain-Barre syndrome. Neurology 35:1096-1104.
54. Hafer-Macko, C., S.-T. Hsieh, C. Y. Li, T. W. Ho, K. A. Sheikh, D. R. Cornblath, G. M. McKhann, A. K. Asbury, and J. W. Griffin. 1996. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann. Neurol. 40:635-644.
55. Hafer-Macko, C., K. A. Sheikh, C. Y. Li, T. W. Ho, D. R. Cornblath, G. M. McKhann, A. K. Asbury, and J. W. Griffin. 1996. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann. Neurol. 39:625-635.
56. Hahn, A. F., T. E. Feasby, A. Steele, D. S. Lovgren, and J. Berry. 1988. Demyelination and axonal degeneration in Lewis rat experimental allergic neuritis depend on myelin dosage. Lab. Invest. 59:115-126.
57. Hartung, H.-P., J. D. Pollard, G. K. Harvey, and K. V. Toyka. 1995. Immunopathogenesis and treatment of the Guillain-Barre syndrome - part I. Muscle Nerve 18:137-153.
58. Hartung, H.-P., J. D. Pollard, G. K. Harvey, and K. V. Toyka. 1995. Immunopathogenesis and treatment of the Guillain-Barre syndrome - part II. Muscle Nerve 18:154-164.
59. Hartung, H.-P., G. Stoll, and K. V. Toyka. 1993. Immune reactions in the peripheral nervous system, p. 418-444. In P. J. Dyck, P. K. Thomas, J. W. Griffin, P. A. Low, and J. F. Poduslo (ed.), Peripheral neuropathy. W. B. Saunders. Philadelphia, Pa.
60. Herbrink, P., H. A. M. Van den Munckhof, M. Bumkens, J. Lindeman, and W. C. Van Dijk. 1988. Human serum antibody response in Campylobacter jejuni enteritis as measured by enzyme-linked immunosorbent assay. Eur. J. Clin. Microbiol. Infect. Dis. 7:388-393.
61. Ho, T. W., S.-T. Hsieh, I. Nachamkin, H. J. Willison, K. Sheikh, J. Kiehlbauch, K. Flanigan, J. C. McArthur, D. R. Cornblath, G. M. McKhann, and J. W. Griffin. 1997. Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection. Neurology 48:717-724.
62. Ho, T. W., G. M. McKhann, and J. W. Griffin. 1998. Human autoimmune neuropathies. Annu. Rev. Neurosci. 21:187-226.
63. Ho, T. W., B. Mishu, C. Y. Li, C. Y. Gao, D. R. Cornblath, J. W. Griffin, A. K. Asbury, M. J. Blaser, and G. M. McKhann. 1995. Guillain-Barre syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 118:597-605.
64. Ho, T. W., H. Willison, I. Nachamkin, C. Y. Li, D. R. Cornblath, A. K. Asbury, J. W. Griffin, and G. M. McKhann. Ami-GD1a antibody distin-guishes axonal from demyelinating forms of Guillain-Barre syndrome. Submitted for publication.
65. Hughes, R. A. C. 1991. Guillain-Barre syndrome. Springer-Verlag, London, United Kingdom.
66. Hughes, R. A. C., and J. H. Rees. 1997. Clinical and epidemiologic features of Guillain-Barre syndrome. Clin. Infect. Dis. 176(Suppl. 2):S92-S98.
67. Hurwitz, E. S., R. C. Holman, D. B. Nelson, and L. B. Schonberger. 1983. National surveillance for Guillain-Barre syndrome: January 1978-March 1979. Neurology 33:150-157.
68. Hutchinson, D. N., and F. J. Bolton. 1984. Improved blood free selective medium for the isolation of Campylobacter jejuni from faecal specimens. J. Clin. Pathol. 37:956-957.
69. Ilyas, A. A., M. C. Dalakas, R. O. Brady, and R. H. Quarles. 1986. Sulfated glucuronyl glycolipids reacting with anti-myelin-associated-glycoprotein monoclonal antibodies including IgM paraproteins in neuropathy: species distribution and partial characterization of epitopes. Brain Res. 385:1-9.
70. Ilyas, A. A., F. A. Mithen, M. C. Dalakas, Z.-W. Chen, and S. D. Cook. 1992. Antibodies to acidic glycolipids in Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy. J. Neurol. Sci. 107:111-121.
71. Ilyas, A. A., H. J. Willison, R. H. Quarles, F. B. Jungawala, D. R. Cornblath, B. D. Trapp, D. E. Griffin, J. W. Griffin, and G. M. McKhann. 1988. Serum antibodies to gangliosides in Guillain-Barre syndrome. Ann. Neurol. 23: 440-447.
72. Jackson, C. E., R. J. Barohn, and J. R. Mendell. 1993. Acute paralytic-syndrome in three American men. Comparison with Chinese eases. Arch. Neurol. 50:732-735.
73. Jacobs, B. C., H. P. Endtz, F. G. A. van der Meche, M. P. Hazenberg, H. A. M. Actereekte, and P. A. van Doorn. 1995. Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome. Ann. Neurol. 37:260-264.
74. Jacobs, B. C., P. I. M. Schmitz, and F. G. A. van der Meehe. 1996. Campylobacter jejuni infection and treatment for Guillain-Barre syndrome. N. Engl. J. Med. 335:208-209.
75. Jones, D. M., E. M. Sutcliffe, and J. D. Abbott. 1985. Serotyping of Campylobacter species by combined use of two methods. Eur. J. Clin. Microbiol. 4:562-565.
76. Kaldor, J., H. Pritchard, A. Serpell, and W. Metcalf. 1983. Serum antibodies in Campylobacter enteritis. J. Clin. Microbiol. 18:1-4.
77. Kaldor, J., and B. R. Speed. 1984. Guillain-Barre syndrome and Campylobacter jejuni: a serologic study. Br. Med. J. 288:1867-1870.
78. Kaplan, J. E., P. J. Poduska, G. C. Mclntosh, R. S. Hopkins, S. W. Ferguson, and L. B. Schonberger. 1985. Guillain-Barre syndrome in Larimer County, Colorado: a high incidence area. Neurology 35:581-584.
79. Kapperud, G., J. Lassen, S. M. Ostroff, and S. Aasen. 1992. Clinical features of sporadic campylobacter infections in Norway. Scand. J. Infect. Dis. 24:741-749.
80. Karmali, M. A., and P. C. Fleming. 1979. Campylobacter enteritis in children. J. Pediatr. 94:527-533.
81. Karmali, M. A., A. E. Simor, M. Roscoe, P. C. Flemming, S. S, Smith, and J. Lane. 1986, Evaluation of a blood-free, charcoal-based, selective medium for the isolation of Campylobacter organisms from feces. J. Clin. Microbiol. 23:456-459.
82. Khoury, S. H. 1978. Guillain-Barre syndrome: epidemiology of an outbreak. Am. J. Epidemiol. 107:433-438.
83. Koobatian, T. J., G. S. Birkhead, M. M. Schramm, and R. L. Vogt. 1991. The use of hospital discharge data for public health surveillance of Guillain-Barre syndrome. Ann. Neurol. 30:618-621.
84. Kornberg, A. J., A. Pestronk, K. Bieser, T. W. Ho, G. M. McKhann, H. S. Wu, and Z. Jiang. 1994. The clinical correlates of high-titer IgG anti-GM1 antibodies. Ann. Neurol. 35:234-237.
85. Koski, C. L., D. K. H. Chou, and F. B. Jungalwala. 1989. Anti-peripheral nerve myelin antibodies in Guillain-Barre syndrome bind a neutral glycolipid of peripheral myelin and cross-react with Forssman antigen. J. Clin. Invest. 84:280-287.
86. Koski, C. L., R. Humphrey, and M. L. Shin. 1985. Anti-peripheral myelin antibodies in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibody by complement component 1 fixation. Proc. Natl. Acad. Sci. USA 82:905-909.
87. Kuroki, S., T. Saida, M. Nukina, T. Haruta, M. Yoshioka, Y. Kobayashi, and H. Nakanishi. 1993. Campylobacter jejuni strains from patients with Guillain-Barre syndrome belong mostly to Penner serogroup 19 and contain B-N-acetylglucosamine residues. Ann. Neurol. 33:243-247.
88. Kusunoki, S., A. Chiba, S. Hitoshi, H. Takizawa, and I. Kanazawa. 1995. Anti-Gal-C antibody in autoimmune neuropathies subsequent to mycoplasma infection. Muscle Nerve 18:409-413.
89. Kusunoki, S., A. Chiba, K. Kon, S. Ando, K. Arisawa, A. Tate, and I. Kanazawa. 1994. N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barre syndrome. Ann. Neurol. 35:570-576.
90. Lane, E. M., R. Batchelor, A. L. Bourgeois, D. H. Burr, and J. G. Olson. 1987. Urine and fecal IgA responses during naturally acquired infection with Campylobacter jejuni. Lancet i:1141. (Letter.)
91. Lang, D. R., B. M. Allos, and M. J. Blaser. 1997. Workshop summary and recommendations regarding the development of Guillain-Barre syndrome following Campylobacter infection. J. Infect. Dis. 176(Suppl. 2):S198-S200.
92. Lastovica, A. J., E. A. Goddard, and A. C. Argent. 1997. Guillain-Barre syndrome in South Africa associated with Campylobacter jejuni O:41 strains. Clin. Infect. Dis. 176(Suppl, 2):S139-S143.
93. Latovitzki, N., N. Suciu-Foca, A. S. Penn, M. R. Olarte, and A. M. Chutorian, 1979. HLA typing and Guillain-Barre syndrome. Neurology 29:743-745.
94. Lawrenson, J. G., A. R. Reid, and G. Allt. 1994, Molecular characterization of anionic sites on the luminal front of endoneurial capillaries in sciatic nerve. J. Neurocytol. 23:29-37.
95. Li, C. Y., P. Xue, C. Y. Gao, W. Q. Tian, R. C. Liu, and C. Yang. 1996. Experimental Campylobacter jejuni infection in the chicken: an animal model of axonal Guillain-Barré syndrome. J. Neurol. Neurosurg. Psychiatry 61:279-284.
96. Lior, H., D. L. Woodward, J. A. Edgar, L. J. Laroche, and P. Gill. 1982. Serotyping of Campylobacter jejuni by slide agglutination based on heatlabile antigenic factors. J. Clin. Microbiol. 15:761-768.
97. Lugaresi, A., M. Ragno, F. Torrieri, G. DiGuglielmo, P. Fermani, and A. Uncini. 1997. Acute motor axonal neuropathy with high titer IgG and IgA anti-GD1a antibodies following Campylobacter enteritis. J. Neurol. Sci. 147:193-200.
98. Mascart-Lemone, F. Q., J. R. Duchateau, J. Oosterom, J.-P. Butzler, and D. L. Delacroix. 1987. Kinetics of anti-Campylobacter jejuni monomeric and polymeric immunoglobulin A1 and A2 response in serum during acute enteritis. J. Clin. Microbiol. 25:1253-1257.
99. Mato, M., S. Ookawara, M. Sugamata, and E. Aikawa. 1984. Evidences for the possible function of the fluorescent granular perithelial cells in brain as scavengers of high molecular-weight waste products. Experientia 40:399-402.
100. McKhann, G. M., D. R. Cornblath, J. W. Griffin, T. W. Ho, C. Y. Li, Z. Jiang, H. S. Wu, G. Zhaori, Y. Liu, L. P. Jou, T. C. Liu, C. Y. Gao, J. Y. Mao, M. J. Blaser, B. Mishu, and A. K. Asbury. 1993. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann. Neurol. 33:333-342.
101. McKhann, G. M., D. R. Cornblath, T. W. Ho, C. Y. Li, A. Y. Bai, H. S. Wu, Q. F. Yei, W. C. Zhang, Z. Zhaori, Z. Jiang, J. W. Griffin, and A. K. Asbury. 1991. Clinical and electrophysiologic aspects of acute paralytic disease of children and young adults in northern China. Lancet 338:593-597.
102. McMyne, P. M. S., J. L. Penner, R. G. Mathias, W. A. Black, and J. N. Hennessy. 1982. Serotyping of Campylobacter jejuni isolated from sporadic cases and outbreaks in British Columbia. J. Clin. Microbiol. 16:281-285.
103. Mishu, B., and M. J. Blaser. 1993. Role of infection due to Campylobacter jejuni in the initiation of Guillain-Barre syndrome. Clin. Infect. Dis. 17: 104-108.
104. Mishu, B., A. A. Ilyas, C. L. Koski, F. Vriesendorp, S. D. Cook, F. A. Mithen, and M. J. Blaser. 1993. Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barre syndrome. Ann. Intern. Med. 118:947-953.
105. Mishu, B., C. M. Patton, and M. J. Blaser. 1993. Microbiologic characteristics of Campylobacter jejuni strains isolated from patients with Guillain-Barre syndrome. Clin. Infect. Dis. 17:538.
106. Molnar, G. K., J. Mertsola, and M. Erkko. 1982. Guillain-Barre syndrome associated with Campylobacter infection. Br. Med. J. 285:652. (Letter.)
107. Monos. D., M. Papaioakim, E. Argyris, E. Iordanidou, I. Nachamkin, A. K. Asbury, T. W. Ho, C. Y. Li, J. W. Griffin, D. R. Cornblath, and G. M. McKhann. 1996. Differential distribution of HLA alleles in two forms of Guillain-Barre syndrome. Ann. Neurol. 40:M121. (Abstract.)
108. Moran, A. P., B. J. Appelmelk, and G. O. Aspinall. 1996. Molecular mimicry of host structures by lipopolysaccharides of Campylobacter and Helicobacter spp.: implications in pathogenesis. J. Endotoxin Res. 3:521-531.
109. Moran, A. P., M. M. Prendergast, and B. J. Appelmelk. 1996. Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease. FEMS Immunol. Med. Microbiol. 16:105-115.
110. Nachamkin, I. 1995. Campylobacter and Arcobacter, p. 483-491. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology. ASM Press, Washington, D.C.
111. Nachamkin, I. 1997. Microbiologic approaches for studying Campylobacter in patients with Guillain-Barre syndrome. J. Infect. Dis. 176(Suppl. 2): S106-S114.
112. Nachamkin, I., H. Ung, and C. M. Patton. 1996. Analysis of HL and O serotypes of Campylobacter strains by the flagellin gene typing system. J. Clin. Microbiol. 34:277-281.
113. Nachamkin, I., and X.-H. Yang. 1989. Human antibody response to Campylobacter jejuni flagellin protein and a synthetic N-terminal flagellin peptide. J. Clin. Microbiol. 27:2195-2198.
114. Nachamkin, I., and X.-H. Yang. 1992. Local immune responses to the Campylobacter flagellin in acute Campylobacter gastrointestinal infection. J. Clin. Microbiol. 30:509-511.
115. Ogawa-Goto, K., N. Funamoto, T. Abe, and K. Nagashima. 1992. Myelin gangliosides of human peripheral nervous system: an enrichment of GM1 in the motor nerve myelin isolated from cauda equina. J. Neurochem. 59: 1844-1849.
116. Oomes, P. G., B. C. Jacobs, M. P. H. Hazenberg, J. R. J. Banffer, and F. G. A. van der Meche. 1995. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barre syndrome, evidence of molecular mimicry. Ann. Neurol. 38:170-175.
117. Osier, W. 1892. Principles and practice of medicine. Appleton, New York, N.Y.
118. Patton, C. M., and I. K. Wachsmuth. 1992. Typing schemes: are current methods useful?, p. 110-128. In I. Nachamkin, M. J. Blaser, and L. S. Tompkins (ed.), Campylobacter jejuni: current status and future trends. American Society for Microbiology, Washington, D.C.
119. Patton, C. M., I. K. Wachsmuth, G. M. Evins, J. A. Kiehlbauch, B. D. Plikaytis, N. Troup, L. Tompkins, and H. Lior. 1991. Evaluation of 10 methods to distinguish epidemic-associated Campylobacter strains. J. Clin. Microbiol. 29:680-688.
120. Penner, J. L., and J. N. Hennessy. 1980. Passive hemagglutination technique for serotyping Campylobacter fetus subsp. jejuni on the basis of soluble heat-stable antigens. J. Clin. Microbiol. 12:732-737.
121. Peterman, A. F., D. D. Daly, F. R. Dion, and H. M. Keith. 1959. Infectious neuronitis (Guillain-Barre syndrome) in children. Neurology 9:533-538.
122. Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group. 1997. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome. Lancet 349:225-230.
123. Poduslo, J. F., and G. L. Curran. 1994. Macromolecular permeability across the blood-nerve and blood-brain barrier. Proc. Natl. Acad. Sci. USA 91: 5705-5709.
124. Prineas, J. W. 1972. Acute idiopathic polyneuritis. An electron microscope study. Lab. Invest. 26:133-147.
125. Pryor, W. M., J. S. Freiman, M. A. Gillies, and R. R. Tuck. 1984. Guillain-Barre syndrome associated with Campylobacter infection. Aust. N. Z. J. Med. 14:687-688.
126. Ramos-Alvarez, M., L. Bessudo, and A. Sabin. 1969. Paralytic syndromes associated with noninflammatory cytoplasmic or nuclear neuronopathy: acute paralytic disease in Mexican children, neuropathologically distinguishable from Landry-Guillain-Barre syndrome. JAMA 207:1481-1492.
127. Rantala, H., M. Uhari, and M. Niemela. 1991. Occurrence, clinical manifestations, and prognosis of Guillain-Barre syndrome. Arch. Dis. Child. 66:706-708.
128. Rees, J. H., N. A. Gregson, and R. A. C. Hughes. 1995. Anti-ganglioside GM1 antibodies in Guillain-Barre syndrome and their relationship to Campylobacter jejuni infection. Ann. Neurol. 38:809-816.
129. Rees, J. H., S. E. Soudain, N. A. Gregson, and R. A. Hughes. 1995. Campylobacter jejuni infection and Guillain-Barre syndrome. N. Engl. J. Med. 333:1374-1379.
130. Rees, J. H., R. W. Vaughan, E. Kondeatis, and R. A. C. Hughes. 1995. HLA-class II alleles in Guillain-Barre syndrome and Miller Fisher syndrome and their association with preceding Campylobacter jejuni infection. J. Neuroimmunol. 62:53-57.
131. Reller, L. B., S. Mirrett, and L. G. Reimer. 1983. Controlled evaluation of an improved selective medium for isolation of Campylobacter jejuni, abstr. C-274, p. 357. In Abstracts of the Annual Meeting of the American Society for Microbiology. American Society for Microbiology, Washington, D.C.
132. Rhodes, K. M., and A. E. Tattersfield. 1982. Guillain-Barre syndrome associated with Campylobacter infection. Br. Med. J. 285:173-174.
133. Roberts, M., H. Willison, A. Vincent, and J. Newsom-Davis. 1994. Serum factor in Miller-Fisher variant of Guillain-Barre syndrome and neurotransmitter release. Lancet 343:454-455.
134. Ropper, A. H. 1986. Severe acute Guillain-Barre syndrome. Neurology 36:429-432.
135. Ropper, A. H. 1988. Campylobacter diarrhea and Guillain-Barre syndrome. Arch. Neurol. 45:655-656.
136. Rostami, A. M. 1995. Guillain Barre syndrome: clinical and immunological aspects. Springer Semin. Immunopathol. 17:29-42.
137. Rostami, A. M. 1997. P2-reactive T cells in inflammatory demyelination of the peripheral nerve. Clin. Infect. Dis. 176(Suppl. 2):S160-S163.
138. Sacks, J. J., S. Lieb, L. M. Baldy, S. Berta, C. M. Patton, M. C. White, W. J. Bigler, and J. J. Witte. 1986. Epidemic campylobacteriosis associated with a community water supply. Am. J. Public Health 76:424-428.
139. Saida, K., T. Saida, M. J. Brown, and D. H. Silberberg. 1979, In vivo demyelination induced by intraneural injection of antigalactoccrebroside serum. Am. J. Pathol. 95:99-116.
140. 3. Infect. Immun. 64:2945-2949.
141. Sanders, E. A., A. C. Peters, J. W. Gratana, and R. A. C. Hughes. 1987. Guillain-Barre syndrome after varicella-zoster infection. Report of two cases. J. Neurol. 234:437-439.
142. Sawant-Mane, S., M. B. Clark, and C. L. Koski. 1991. In vitro demyelination by serum antibody from patients with Guillain-Barre syndrome requires terminal complement complexes. Ann. Neurol. 29:397-404.
143. Sawant-Mane, S., A. Estep, 3rd, and C. L. Koski, 1994. Antibody of patients with Guillain-Barre syndrome mediates complement-dependent cytolysis of rat Schwann cells: susceptibility to cytolysis reflects Schwann cell phenotype. J. Neuroimmunol. 49:145-152.
144. Schonberger, L. B., E. S. Hurwitz, P. Katona, R, C. Holman, and D. J. Bregman. 1981. Guillain-Barre syndrome: its epidemiology and associations with influenza vaccination. Ann. Neurol. 9:31-38.
145. Sheikh, K. A., I. Nachamkin, T. W. Ho, H. J. Willison, J. Veitch, B. S. Ung, C. Y. Li, B.-G. Shen, D. R. Cornblath, A. K. Asbury, G. M. McKhann, and J. W. Griffin. Campylobacter jejuni lipopolysaccharides in Guillain-Barre syndrome: molecular mimicry and host susceptibility. Neurology, in press.
146. Sjogren, E., G. B. Lindblom, and B. Kaijser. 1987. Comparison of different procedures, transport media, and enrichment media for isolation of Campylobacter species from healthy laying hens and humans with diarrhea. J. Clin. Microbiol. 25:1966-1968.
147. Skirrow, M. B. 1977. Campylobacter enteritis: a "new" disease. Br. Med. J. ii:9-11.
148. Sliman, N. A. 1978. Outbreak of Guillain-Barre syndrome associated with water pollution. Br. Med. J. 1:751-752.
149. Speed, B., J. Kaldor, and P. Cavanagh. 1984. Guillain-Barre syndrome associated with Campylobacter jejuni enteritis. J. Infect. Dis. 8:85-86.
150. Speed, B. R., J. Kaldor, J. Watson, H. Newton-John, W. Tee, D. Noonan, and B. W. Dwyer. 1987. Campylobacter jejuni/Campylobacter coli associated Guillain-Barre syndrome. Med. J. Aust. 147:13-16.
151. Stewart, G. J., J. D. Pollard, J. G. McLeod, and C. M. Wolnizer. 1978. HLA antigens in the Landry-Guillain-Barre syndrome and chronic relapsing polyneuritis. Ann. Neurol. 4:285-289.
152. Sugita, K., M. Ishii, J. Takanashi, H. Niimi, and N. Yuki. 1994. Guillain-Barre syndrome associated with IgM anti-GM1 antibody following Campylobacter jejuni enteritis. Eur. J. Pediatr. 153:181-183.
153. Sumner, A., G. Said, I. Idy, and S. Metral. 1982. Syndrome de Guillain-Barre. Rev. Neurol. 138:17-24.
154. Sumner, A. J. 1980. The physiology of peripheral nerve disease. W. B. Saunders, Philadelphia, Pa.
155. Svedhem, A., and B. Kaijser. 1980. Campylobacter fetus subspecies jejuni: a common cause of diarrhea in Sweden. J. Infect. Dis. 142:353-359.
156. Tauxe, R. V. 1992. Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations, p. 9-19. In I. Nachamkin, M. J. Blaser, and L. S. Tompkins (ed.), Campylobacter jejuni: current status and future trends. American Society for Microbiology, Washington, D.C.
157. Taylor, D. N., P. Echeverria, C. Pitarangsi, J. Seriwatana, L. Bodhidatta, and M. J. Blaser. 1988. Influence of strain characteristics and immunity on the epidemiology of Campylobacter infections in Thailand. J. Clin. Microbiol. 26:863-868.
158. Taylor, N. S., M. A. Elenberger, P. Y. Wu, and J. G. Fox. 1989. Diversity of serotypes of Campylobacter jejuni and Campylobacter coli isolated in laboratory animals. Lab. Anim. Sci. 39:219-221.
159. Thomas, P. K. 1992. The Guillain-Barre syndrome: no longer a simple concept. J. Neurol. 239:361-362.
160. Thornton, C. A., A. S. Latif, and J. C. Emmanuel. 1991. Guillain-Barre syndrome associated with human immunodeficiency virus infection in Zimbabwe. Neurology 41:812-815.
161. Triggs, W. J., D. Cros, S. C. Gominak, G. Zuniga, A. I. Beric, B. T. Shahani, A. H. Ropper, and S. M. Roongta. 1992. Motor nerve inexcitability in Guillain-Barre syndrome. Brain 115:1291-1302.
162. Tsukada, N., C. S. Koh, A. Inoue, and N. Yanagisawa. 1987. Demyelinating neuropathy associated with hepatitis B virus infection. J. Neurol. Sci. 77: 203-216.
163. Valenciano, E. N., F. Perez-Gallardo, A. Gonzales, and J. Enrech. 1971. Outbreak of paralytic illness of unknown etiology in Albecete, Spain. Am. J. Epidemiol. 94:450-456.
164. Valenstein, P., M. Pfaller, and M. Yungbluth. 1996. The use and abuse of routine stool microbiology: a College of American Pathologists Q-probes study of 601 institutions. Arch. Pathol. Lab. Med. 120:206-211.
165. van der Meche, F. G. A., P. I. M. Schmitz, and Dutch Guillain-Barre Study Group. 1992. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome. N. Engl. J. Med. 326: 1123-1129.
166. Vriesendorp, F. J. 1997. Insights into Campylobacter jejuni induced Guillain-Barre syndrome from the Lewis rat model of experimental allergic neuritis. Clin. Infect. Dis. 176(Suppl. 2):S164-S168.
167. Vriesendorp, F. J., B. Mishu, M. Blaser, and C. L. Koski. 1993. Serum antibodies to GM1, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barre syndrome and controls: correlation and prognosis. Ann. Neurol. 34:130-135.
168. Willison, H., G. O'Hanlon, G. Paterson, C. P. O'Leary, J. Veitch, G. Wilson, M. Roberts, T. Tang, and A. Vincent. 1997. Mechanisms of action of anti-GM1 and anti-GQ1b ganglioside antibodies in Guillain-Barre syndrome. Clin. Infect. Dis. 176(Suppl. 2):S144-S149.
169. Willison, H. J., J. Veitch, G. Patterson, and P. G. E. Kennedy. 1993. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J. Neurol. Neurosurg. Psychiatry 56:204-206.
170. Winer, J. B., R. A. C. Hughes, and C. Osmond. 1988. A prospective study of acute idiopathic neuropathy. 2. Antecedent events. J. Neurol. Neurosurg. Psychiatry 51:613-618.
171. Winer, S. J., and J. G. Evans. 1993. Guillain-Barre syndrome in Oxfordshire: clinical features in relation to age. Age Ageing 22:164-170.
172. Wroe, S. J., and L. D. Blumhardt. 1985. Polyneuritis with cranial nerve involvement following Campylobacter jejuni infection. J. Neurol. Neurosurg. Psych. 48:593.
173. Wu, S.-J., G. Pazzaglia, R. L. Haberberger, J. J. Oprandy, D. G. Sieckmann, D. M. Watts, and C. Hayes. 1993. Detection of immunoglobulin A in urine specimens from children with Campylobacter-associated diarrhea by a chemiluminescent indicator-based Western immunodot assay. J. Clin. Microbiol. 31:1394-1396.
174. Yang, L. J. S., C. B. Zeller, N. L. Shaper, M. Kiso, A. Hasegawa, R. E. Shapiro, and R. L. Schnaar. 1996. Gangliosides are neuronal ligands for myelin-associated glycoprotein. Proc. Natl. Acad. Sci. USA 93:814-818.
175. Yuki, N. 1994. Pathogenesis of axonal Guillain-Barre syndrome: hypothesis. Muscle Nerve 17:680-682.
176. Yuki, N., S. Handa, T. Tai, M. Takahashi, K. Saito, Y. Tsujino, and T. Taki. 1995. Ganglioside-like epitopes of lipopolysaccharides from Campylobacter jejuni (PEN 19) in three isolates from patients with Guillain-Barre syndrome. J. Neurol. Sci. 130:112-116.
177. Yuki, N., S. Sato, S. Fujimoto, Y. Yamada, A. Kinoshita, and T. Itoh. 1992. Serotype of Campylobacter jejuni, HLA, and the Guillain-Barre syndrome. Muscle Nerve 16:968-969.
178. Yuki, N., S. Sato, T. Itoh, and T. Miyatake. 1991. HLA-B34 and acute axonal polyneuropathy following Campylobacter infection. Neurology 41: 1561-1563.
179. Yuki, N., S. Sato, S. Tsuji, T. Ohsawa, and T. Miyatake. 1993. Frequent presence of anti-GO1b antibody in Fisher's syndrome. Neurology 43:414-417.
180. Yuki, N., M. Takahashi, Y. Tagawa, K. Kashiwase, K. Tadokoro, and K. Saito. 1997. Association of Campylobacter jejuni serotype and antiganglioside antibody in Guillain-Barre syndrome and Fisher's syndrome. Ann. Neurol. 42:28-33.
181. Yuki, N., T. Taki, F. Inagaki, T. Kasama, M. Takahashi, K. Saito, S. Handa, and T. Miyatake. 1993. A bacterium lipopolysaccharide that elicits Guillain-Barre syndrome has a GM1 ganglioside structure. J. Exp. Med. 178:1771-1775.
182. Yuki, N., T. Taki, M. Takahashi, K. Saito, T. Tai, T. Miyatake, and S. Handa. 1994. Penner's serogroup 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1a epitope. Infect. Immun. 62:2101-2103.
183. Yuki, N., T. Taki, M. Takahashi, K. Saito, H. Yoshino, T. Tai, S. Handa, and T. Miyatake. 1994. Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fishers syndrome. Ann. Neurol. 36:791-793.
184. Yuki, N., M. Yamada, S. Sato, E. Ohama, Y. Kawase, F. Ikuta, and T. Miyatake. 1993. Association of IgG anti-GD1a antibody with severe guillain barre syndrome. Muscle Nerve 16:642-647.
185. Yuki, N., H. Yoshino, S. Sato, and T. Miyatake. 1990. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 40:1900-1902.
186. Yuki, N., H. Yoshino, S. Sato, K. Shinozawa, and T. Miyatake. 1992. Severe acute axonal form of Guillain-Barre syndrome associated with IgG anti-GD1a antibodies. Muscle Nerve 15:899-903.